Sample Preparation, LC/MS, SFC, LC/SQ, PrepLC
IndustriesPharma & Biopharma
ManufacturerWaters
Significance of the Topic
Natural products remain a primary source of bioactive molecules for pharmaceuticals, nutraceuticals, cosmetics and supplements due to their structural diversity and high biological activity. Efficient isolation of these compounds from complex plant matrices is critical but often hampered by laborious workflows, excessive solvent consumption and limited throughput. Integrating supercritical fluid extraction (SFE) and preparative supercritical fluid chromatography (SFC) can address these challenges by offering selective extraction, orthogonal separations and reduced environmental impact.
Objectives and Study Overview
The study aimed to improve the overall productivity of isolating a naturally occurring terpene derivative with anticancer activity from plant biomass. Three purification workflows were compared: medium-pressure liquid chromatography (MPLC) followed by high-performance liquid chromatography (HPLC), MPLC followed by SFC, and a two-stage SFC approach. Metrics included throughput (g per 24 h), solvent use and final product purity.
Methodology and Instrumentation
The workflow began with extraction of ground plant material using:
- Conventional methanol sonication (40 °C, 1 h)
- Supercritical CO2 with 1 mL/min co-solvent (methanol/IPA/hexane 1:1:1) on a Waters MV-10 ASFE System
- Prep 100q SFC MS-Directed System on Viridis Silica 2-EP column
- SFC 80 Preparative System on Viridis Silica 2-EP and Nitro columns
- AutoPurification LC System for HPLC fractions
Key Results and Discussion
SFE yielded an extract enriched in the target terpene (m/z 391), with a markedly simpler impurity profile compared to methanol extraction. In the MPLC+HPLC route, a demethoxylated impurity (m/z 361) co-eluted closely with the target in reversed-phase HPLC, limiting maximum injection volumes and achieving only 0.25 g/24 h throughput with high methanol use. Replacing HPLC with SFC on a polar 2-EP column improved resolution and reversed elution order, enabling higher sample loads (600 µL vs. 80 µL) and yielding 2.25 g/24 h (9× productivity increase) with a 21% reduction in organic solvent. A fully SFC-based workflow using sequential 2-EP and Nitro columns exploited orthogonal retention mechanisms (polar and π-π interactions). This approach eliminated key impurities, increased throughput to 3.50 g/24 h (16× vs. MPLC+HPLC) and cut organic solvent use by ~90%. SFC fractions were smaller and dried rapidly under mild conditions, minimizing thermal degradation and simplifying solvent removal.
Benefits and Practical Applications
- Higher isolation throughput through increased loading and shorter run times
- Substantially lower organic solvent consumption and reduced waste
- Improved selectivity via orthogonal column chemistries
- Milder recovery conditions, preserving sensitive compounds
- Scalability for pharmaceutical, nutraceutical and cosmetic industries
Future Trends and Potential Applications
Emerging developments may include expanded SFC stationary phases, integration with high-resolution MS detection, continuous flow and automation for process intensification. Green extraction and purification strategies based on supercritical fluids are poised to play a central role in sustainable natural product drug discovery and industrial manufacturing.
Conclusion
Combining SFE and multi-step preparative SFC offers a powerful, eco-friendly platform for isolating bioactive natural products. This integrated approach outperforms conventional MPLC/HPLC workflows in throughput, solvent efficiency and purity, addressing key bottlenecks in natural product research and development.
Instrumentation
- Waters MV-10 ASFE System with ChromScope Sample Prep Software
- Waters ACQUITY UPLC H-Class System with SQD2 detector
- Waters ACQUITY UPC2-MS System with TQD detector
- Waters Prep 100q SFC MS-Directed System
- Waters SFC 80 Preparative System
References
- Harvey AL. Strategies for discovering drugs from previously unexplored natural products. Drug Discov Today. 2000;5(7):294–300.
- Harvey AL. Natural products in drug discovery. Drug Discov Today. 2008;13(19–20):894–901.
- Li JWH, Vederas JC. Drug discovery and natural products: end of an era or endless frontier? Science. 2009;325(5937):161–165.
- Harvey AL. Natural products as a screening source. Curr Opin Chem Biol. 2007;11:480–484.
- Sarker SD, Latif Z, Gray AI. Natural product isolation: an overview. In: Natural Product Isolation, 2nd ed. Humana Press; 2006. p.1–25.
- Sticher O. Natural product isolation. Nat Prod Rep. 2008;25:517–554.
- Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 2005;4:206–220.
- Ramírez P, García-Risco MR, Santoyo S, Señoráns FJ, Ibáñez E, Reglero G. Application of SFE–SFC for bioactive compound isolation. J Pharm Biomed Anal. 2006;41:1606–1613.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.